-+ 0.00%
-+ 0.00%
-+ 0.00%
Health Yuan announced that on November 14, 2026, the National Medical Security Administration and the Ministry of Human Resources and Social Security issued the “National Basic Medical Insurance, Maternity Insurance and Work Injury Insurance Drug Catalogue”. The company and its subsidiaries included a total of 221 products, including 94 Class A and 127 Class B. Mapasisavir capsules were included in category B for the first time through negotiations. None of the company's products have left the catalog, and the original products continue to be retained. It is expected to have a positive impact on the company's business performance in the future. This edition of the catalogue will be officially implemented on January 1, 2027, and is not expected to have a significant impact on the company's current business performance.
Share
Listen to the news
Health Yuan announced that on November 14, 2026, the National Medical Security Administration and the Ministry of Human Resources and Social Security issued the “National Basic Medical Insurance, Maternity Insurance and Work Injury Insurance Drug Catalogue”. The company and its subsidiaries included a total of 221 products, including 94 Class A and 127 Class B. Mapasisavir capsules were included in category B for the first time through negotiations. None of the company's products have left the catalog, and the original products continue to be retained. It is expected to have a positive impact on the company's business performance in the future. This edition of the catalogue will be officially implemented on January 1, 2027, and is not expected to have a significant impact on the company's current business performance.
Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.
What's Trending